Evaluation of proton pump inhibitors and risks of gastric cancer

被引：2
|
作者：
Zeng, Ruijie [1 ,2 ]
Sha, Weihong [1 ]
Wang, Jinghua [3 ]
Zhuo, Zewei [1 ]
Wu, Huihuan [1 ]
Leung, Felix W. [4 ,5 ]
Chen, Hao [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China
[2] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
[4] VA Greater Los Angeles Healthcare Syst, Sepulveda Ambulatory Care Ctr, Los Angeles, CA USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
GUT | 2022年 / 71卷 / 09期
基金：
中国国家自然科学基金;
关键词：
proton pump inhibition; gastric cancer; ASSOCIATION;
D O I：
10.1136/gutjnl-2021-326291
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1924 / 1926
页数：3
相关论文
共 50 条
  • [41] Transmucosal Gastric Leak Induced by Proton Pump Inhibitors
    Lisa J. Murray
    Melissa Gabello
    David S. Rudolph
    Christopher P. Farrell
    Melissa Morgan
    Aaron P. Martin
    James C. Underwood
    M. Carmen Valenzano
    James M. Mullin
    Digestive Diseases and Sciences, 2009, 54
  • [42] Proton pump inhibitors: balancing the benefits and potential fracture risks
    Richards, J. Brent
    Goltzman, David
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (04) : 306 - 307
  • [43] Risks of Proton Pump Inhibitors for Patients With Cirrhosis: The Controversy Remains
    de Mattos, Angelo Zambam
    da Silva Miozzo, Suelen Aparecida
    Tovo, Cristiane Valle
    de Mattos, Angelo Alves
    HEPATOLOGY, 2017, 66 (01) : 295 - 296
  • [44] Proton pump inhibitors: Risks of long-term use
    Eusebi, Leonardo Henry
    Rabitti, Stefano
    Artesiani, Maria Laura
    Gelli, Dania
    Montagnani, Marco
    Zagari, Rocco Maurizio
    Bazzoli, Franco
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (07) : 1295 - 1302
  • [45] Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population
    Zhu, Wengen
    Hong, Kui
    INTERNATIONAL HEART JOURNAL, 2017, 58 (02) : 163 - 166
  • [46] Proton pump inhibitors are gastric mucosa carbonic anhydrase inhibitors as well
    Puscas, I
    Gilau, L
    Coltau, M
    Maghiar, A
    Domuta, G
    Maghiar, T
    Puscas, C
    Micle, O
    Magheru, S
    Micle, L
    Magheru, C
    GASTROENTEROLOGY, 2001, 120 (05) : A156 - A156
  • [47] Proton pump inhibitors and risk of gastric cancer: population-based cohort study
    Abrahami, Devin
    McDonald, Emily Gibson
    Schnitzer, Mireille E.
    Barkun, Alan N.
    Suissa, Samy
    Azoulay, Laurent
    GUT, 2022, 71 (01) : 16 - 24
  • [48] Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD
    Peng, Yen-Chun
    Huang, Lam-Ru
    Lin, Cheng-Li
    Hsu, Wan-Yun
    Chang, Chi-Sen
    Yeh, Hong-Zen
    Kao, Chia-Hung
    GUT, 2019, 68 (02) : 374 - +
  • [49] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    Poulsen, A. H.
    Christensen, S.
    McLaughlin, J. K.
    Thomsen, R. W.
    Sorensen, H. T.
    Olsen, J. H.
    Friis, S.
    BRITISH JOURNAL OF CANCER, 2009, 100 (09) : 1503 - 1507
  • [50] Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    A H Poulsen
    S Christensen
    J K McLaughlin
    R W Thomsen
    H T Sørensen
    J H Olsen
    S Friis
    British Journal of Cancer, 2009, 100 : 1503 - 1507
12345